⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AQST News
Aquestive Therapeutics, Inc. Common Stock
Pomerantz LLP Updates Investors on Legal Action Brought Against Aquestive Therapeutics, Inc. – AQST
accessnewswire.com
AQST
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AQST
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST
globenewswire.com
AQST
Pomerantz LLP Shares Class Action Details With Shareholders in Aquestive Therapeutics, Inc. – AQST
accessnewswire.com
AQST
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AQST
Pomerantz LLP Shares Class Action Details With Investors in Aquestive Therapeutics, Inc. – AQST
accessnewswire.com
AQST
AQST CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 Ready to Announce with Confidence?
newsfilecorp.com
AQST
AQST Shareholder Alert: Aquestive Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm
globenewswire.com
AQST
Pomerantz LLP Issues Important Reminder to Investors in Aquestive Therapeutics, Inc. of Class Action Lawsuit – AQST
accessnewswire.com
AQST
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AQST